Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06033248
Status:
RECRUITING
Last Update Posted:
2023-09-13
First Post:
2023-09-05
Brief Title:
Using Urine Samples to Identify Lung Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Study Overview
Official Title:
Validation and Determination of Feasibility for Clinical Use of an Animal Biosensor Platform to Detect Non-Small Cell Lung Cancer-Specific Volatile Organic Compounds in Urine Samples
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The researchers are doing this study to test the ability of an animal biosensor platform ABP to detect NSCLC Participants in this study will either be diagnosed with NSCLC suspected to have NSCLC or have not been diagnosed or suspected to have NSCLC
The ABP test uses laboratory animals that are trained to detect by smell different chemicals in urine Studies show that people with lung cancer have unique chemicals in their urine that are not present in people without lung cancer and researchers think these chemicals can be used to identify people with lung cancer without the need for invasive procedures like biopsy
The ABP test uses laboratory animals that are trained to detect by smell different chemicals in urine Studies show that people with lung cancer have unique chemicals in their urine that are not present in people without lung cancer and researchers think these chemicals can be used to identify people with lung cancer without the need for invasive procedures like biopsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None